|
Oxygen Biotherapeutics’ (OXBT) Management Discusses Q4 2014 Results …
Seeking Alpha (registration) … the March 2014, $59 million public offering of common stock proceeds from the July 2013, $5.4 million public offering of Series C Preferred Stock and Warrants, and the exercise of certain outstanding warrants throughout the year for proceeds of $7 … Oxygen Biotherapeutics Announces Fiscal Year 2014 Financial ResultsWall Street Journal |
